stars 1 stars 2 stars 3

Codagenix Inc. is a clinical stage biotechnology company leading a new era of live vaccines and viral therapeutics. The company’s breakthrough platform brings together live-attenuated virus design with cutting-edge codon deoptimization for powerful synthetic biology-based solutions to take on our biggest threats in infectious disease, cancer and animal health. Codagenix represents the next wave in vaccine technology, untethered from traditional, time-consuming and unpredictable approaches to attenuating viruses. Current Areas of focus are: - Dengue Fever - Influenza - Yellow Fever - Polio - RSV - COVID-19 - Zika - Cancer Virotherapeutics - Animal Health

Codagenix Inc. Questions

The Codagenix Inc. annual revenue was $1 million in 2026.

Jeffrey Fu is the Chief Business Officer of Codagenix Inc..

9 people are employed at Codagenix Inc..

Codagenix Inc. is based in Farmingdale, New York.

The NAICS codes for Codagenix Inc. are [32541, 3254, 325, 325414, 32].

The SIC codes for Codagenix Inc. are [28, 283].

Top Codagenix Inc. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users